News
-
-
COMMUNIQUÉ DE PRESSE
Telomir Demonstrates Telomir-1 Reverses Epigenetic Gene Silencing of STAT1, Restoring Tumor Suppressor in Human Prostate Cancer Cells, Outperforming Chemotherapy and Rapamycin
Telomir-1 shows strong epigenetic effects in reversing STAT1 gene silencing, achieving greater efficacy than Paclitaxel and Rapamycin in aggressive prostate cancer models -
-
-
COMMUNIQUÉ DE PRESSE
Telomir Pharmaceuticals Prevents Cellular Aging in Patient-Derived Cells from Children with Progeria - an Ultra-Rare Genetic Disorder that Causes Rapid Aging
Telomir Pharmaceuticals, Inc. announces preclinical data showing lead candidate Telomir-1 prevents cellular aging in children with progeria. Study uses cell lines from Progeria Research Foundation -
-
-
COMMUNIQUÉ DE PRESSE
Telomir Pharmaceuticals Announces Telomir-1 Demonstrates Dose-Dependent Restoration of Neurological, Liver and Kidney Functions in Preclinical Wilson's Disease Model
Telomir-1 reverses tremors, ataxia, liver & kidney damage in Wilson's disease animal model, showing regenerative potential across genetic disorders -
-
